Serine/threonine kinase inhibitors
US9388171B2 · kind B2 · utility
5Cited by
1References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2013 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Oct 7, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the formula I wherein R2, X and Z as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for treating hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.